一眼看:最大的尼曼·皮克型C1队列,有602名患者在15年内被诊断出患病
Pilar Guatibonza Moreno1, Luba M Pardo1, Catarina Pereira1
1CENTOGENE GmbH, Rostock, Germany.
European journal of human genetics : EJHG
|July 11, 2023
概括
这项研究分析了602名尼曼-皮克型C1疾病 (NPC1) 患者的遗传和临床数据,确定了新的变异和基因型-表型相关性. 研究结果揭示了生物标志物PPCS在评估NPC1疾病严重程度和进展中的实用性.
科学领域:
- 遗传学和罕见疾病.
- 神经遗传学 神经遗传学
- 生物标志物研究的研究.
背景情况:
- 尼曼-皮克C1型疾病 (NPC1) 是一种严重的致命遗传疾病,目前没有有效的治疗方法.
- 了解NPC1的遗传基础和基因型-表型相关性对于潜在的治疗策略至关重要.
研究的目的:
- 分析来自大量NPC1患者队列的临床,遗传和生物标记数据.
- 为了识别新的NPC1变异,并建立基因型-表型关系.
- 评估生物标志物PPCS在疾病严重程度评估中的有用性.
主要方法:
- 分析了来自47个国家的602名NPC1患者的临床,遗传和PPCS生物标记数据.
- 使用的人类表现型本体学 (HPO) 术语用于临床数据剖析.
- 进行了基因型-表型相关性分析.
主要成果:
- 在NPC1中确定了287种独特的致病性/可能致病性 (P/LP) 变异,其中包括73种以前未发表的变异.
- 功能丧失 (LoF) 变体与早期诊断和生物标志物水平增加相关.
- 特定变异 (例如,p.(P1007A,p.(S954L)) 与晚期发病和较轻微的表型相关.
结论:
- 这项研究呈现了迄今为止最大和最多样化的NPC1患者队列.
- 生物标志物PPCS显示了潜在的NPC1疾病严重程度和进展.
- 确定了常见NPC1变异的新型基因型-表型关系,有助于变异分类和理解疾病异质性.
相关概念视频
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Chronic Pancreatitis II: Collaborative Care
115
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
115
Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Cystic Fibrosis: Management
195
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
195
Cystic Fibrosis: Pathogenesis
293
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
293


